Complete metabolic response to combined BRAF/MEK inhibition (dabrafenib-trametinib) in BRAF V600E-mutated metastatic parotid adenocarcinoma: A case report

By A. Kouanga, M. Paillard, Thierry Nguyen, C. Borg. 2026